Navigation Links
Risk of preeclampsia in pregnant mothers may be inherited

Dutch scientists have found out that the condition of preeclampsia that may cause complications in giving birth may be passed on from mothers to their daughters.//

Preeclampsia is a condition that is characterized by high blood pressure, protein in the urine and swelling of hands and feet. This is one of the pregnancy-induced conditions that may cause severe complications to the pregnant mother and unborn child.

Scientists have identified a gene called STOX1 or C10orf24 that contained five different missense mutations, which are identical between sisters. This exists with preeclampsia phenotype and follows inheritance from the mother. Four STOX1 transcripts are articulated in early placenta. STOX1 is said to control polyploidization of extravillus trophoblast that leads to preeclampsia. This is because how the placenta develops in the early stages of pregnancy is what leads to the diseases of preeclampsia and others.

The scientists hope that one single blood test will be able to predict the gene that gives a woman with the STOX1 genotype a fift percent chance of having preeclampsia.

The study is published in the April issue of Nature Genetics.


'"/>




Page: 1

Related medicine news :

1. Protein marker to detect early preeclampsia
2. Protein Molecules in blood predict preeclampsia development
3. Starvation in pregnant women can cause heart disease to their children
4. CDC reveals relationship between prepregnant weight and heart defects in infants
5. Watch your weight when pregnant
6. Relief to pregnant women using fertility drugs
7. Watch your weight when pregnant
8. Ginger to reduce nausea for pregnant women
9. Obesity, diabetes in pregnant women affects babies
10. No need to hassel with children at meal time, just eat when pregnant!
11. Premature birth linked with pregnant women on night shift
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/29/2017)... CT (PRWEB) , ... March 29, 2017 , ... HealthCareMandA.com ... —on Thursday, April 20, 2017, at 1:00 PM ET. A recording of the webinar ... the Interactive Webinar Series. , Home health and hospice companies are still popular targets ...
(Date:3/29/2017)... ... March 29, 2017 , ... Immunotherapy has emerged as one ... cancers and is touted to be the next revolution in our fight against this ... in the form of immune checkpoint inhibitors such as PD-1 and PD-L1 inhibitors. , ...
(Date:3/29/2017)... PA (PRWEB) , ... March ... ... eastern suburbs and South Hills of Pittsburgh now have easier access to ... Pennsylvania only by Allegheny Health Network (AHN). Orthopaedic surgeons at Forbes Hospital ...
(Date:3/29/2017)... ... ... The Wharton School of the University of Pennsylvania is pleased to announce that ... gift to establish the Ken Moelis and Julie Taffet Moelis Advance Access Program ... for highly-qualified Penn undergraduates whose academic and career interests expand traditional notions of business ...
(Date:3/29/2017)... ... March 29, 2017 , ... VisualSP has helped over 1.5 million SharePoint ... option for on-premises installation of its Help System for SharePoint was at the farm ... into the entire tenant. , The company recently released a modified version of ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... Wound care devices and products are used ... The industry mainly consists of establishments engaged in manufacturing ... wounds caused by mechanical, chemical, thermal, and radiogenic trauma; ... diabetes, skin related diseases, immunological diseases, and other chronic ... the largest region in the wound care devices market ...
(Date:3/29/2017)... YORK , March 29, 2017 Global intravenous ... US$ 3 billion by 2021, growing at a CAGR of ... iron prescribed by a doctor to treat anemia or other ... iron level in the body. However, in some cases, oral ... the body and intravenous (IV) iron therapy comes into the ...
(Date:3/29/2017)... 2017  Novartis announced today that the US ... company,s Biologics License Application (BLA) filing and granted ... antigen receptor T cell (CAR-T) therapy, in relapsed ... with B-cell acute lymphoblastic leukemia (ALL). This is ... CAR-T. The priority review designation is expected to ...
Breaking Medicine Technology: